New cancer drugs being held back to save Government money, says GlaxoSmithKline bossThe head of Britain biggest drugs company has accused the Government of systematically delaying the introduction of new cancer drugs in order to save money.
Mar. 01, 2012
1.Trump is Right: GOP Debate Audience is Packed Full of Republican Donors
2.Government Agents Hunt Woman Down After Seeing Facebook Picture Of Her Rehabilitating Baby Squirrels
3.Florida Cops Unload On Man Holding Gun Fearing Home Invasion After Knock On Door At 1AM, Had Wrong House
4.VIDEO: Americans Express Support When Told Obama Had 'Launched A Preemptive Nuclear Strike On Russia'
5.Mandatory Mental Illness Screening and The Drive to Confiscate Firearms
6.Three Reasons to Be Worried About The Economy
7.Miami Police Retaliate Against Female Driver Who Filmed Herself Pulling Over Cop
8.Trump On Debate Audience: "They Gave Me 20 Tickets"
GlaxoSmithKline chief executive Sir Andrew Witty warned that ministers were making false economies as they tried to grapple with the deficit in the public finances.